LungLife AI Statistics

Total Valuation

LungLife AI has a market cap or net worth of GBP 1.27 million. The enterprise value is -633,048.

Market Cap	1.27M
Enterprise Value	-633,048

Important Dates

The last earnings date was Thursday, May 22, 2025.

Earnings Date	May 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+5.67%
Shares Change (QoQ)	+11.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	55.45
PB Ratio	0.20
P/TBV Ratio	0.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.18
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.18

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.03.

Current Ratio	2.83
Quick Ratio	2.67
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-140.09

Financial Efficiency

Return on equity (ROE) is -48.59% and return on invested capital (ROIC) is -30.30%.

Return on Equity (ROE)	-48.59%
Return on Assets (ROA)	-27.28%
Return on Invested Capital (ROIC)	-30.30%
Return on Capital Employed (ROCE)	-57.70%
Revenue Per Employee	2,868
Profits Per Employee	-441,825
Employee Count	15
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.67%
50-Day Moving Average	5.84
200-Day Moving Average	11.33
Relative Strength Index (RSI)	18.41
Average Volume (20 Days)	52,525

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LungLife AI had revenue of GBP 22,947 and -3.53 million in losses. Loss per share was -0.13.

Revenue	22,947
Gross Profit	22,947
Operating Income	-3.66M
Pretax Income	-3.53M
Net Income	-3.53M
EBITDA	-3.45M
EBIT	-3.66M
Loss Per Share	-0.13

Full Income Statement

Balance Sheet

The company has 2.07 million in cash and 166,958 in debt, giving a net cash position of 1.91 million.

Cash & Cash Equivalents	2.07M
Total Debt	166,958
Net Cash	1.91M
Net Cash Per Share	n/a
Equity (Book Value)	6.28M
Book Value Per Share	0.22
Working Capital	1.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.37 million and capital expenditures -60,928, giving a free cash flow of -3.43 million.

Operating Cash Flow	-3.37M
Capital Expenditures	-60,928
Free Cash Flow	-3.43M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-15,941.26%
Pretax Margin	-15,389.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LungLife AI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.67%
Shareholder Yield	n/a
Earnings Yield	-277.81%
FCF Yield	-269.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LungLife AI has an Altman Z-Score of -5.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.25
Piotroski F-Score	n/a